EDGAR Filing Documents for 0001213900-24-038547

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001213900-24-038547

Filing Date

2024-05-01

Accepted

2024-05-01 16:45:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS	ea0205102-424b5_cerotherap.htm	424B5	2497625
2	GRAPHIC	image_001.jpg	GRAPHIC	3616
3	GRAPHIC	image_002.jpg	GRAPHIC	10139
4	GRAPHIC	image_003.jpg	GRAPHIC	36859
5	GRAPHIC	image_004.jpg	GRAPHIC	18017
6	GRAPHIC	image_005.jpg	GRAPHIC	20325
7	GRAPHIC	image_006.jpg	GRAPHIC	40764
8	GRAPHIC	image_007.jpg	GRAPHIC	19145
9	GRAPHIC	image_008.jpg	GRAPHIC	22272
10	GRAPHIC	image_009.jpg	GRAPHIC	21428
11	GRAPHIC	image_010.jpg	GRAPHIC	12052
12	GRAPHIC	image_011.jpg	GRAPHIC	13661
13	GRAPHIC	image_012.jpg	GRAPHIC	27912
14	GRAPHIC	image_013.jpg	GRAPHIC	3616
	Complete submission text file	0001213900-24-038547.txt		2844592

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080

Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376

CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)